Form 8-K - Current report:
SEC Accession No. 0001213900-24-088119
Filing Date
2024-10-16
Accepted
2024-10-16 14:10:03
Documents
17
Period of Report
2024-10-16
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0217785-8k_180life.htm   iXBRL 8-K 41865
2 FORM OF WARRANT TO PURCHASE SHARES OF COMMON STOCK ea021778501ex4-1_180life.htm EX-4.1 91358
3 FORM OF WARRANT INDUCEMENT AGREEMENT, BY AND BETWEEN THE COMPANY AND HOLDER ea021778501ex10-1_180life.htm EX-10.1 70506
4 FINANCIAL ADVISORY AGREEMENT, DATED AS OF OCTOBER 16, 2024, BETWEEN A.G.P./ALLIA ea021778501ex10-2_180life.htm EX-10.2 33325
  Complete submission text file 0001213900-24-088119.txt   513689

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE atnf-20241016.xsd EX-101.SCH 3787
6 XBRL DEFINITION FILE atnf-20241016_def.xml EX-101.DEF 26629
7 XBRL LABEL FILE atnf-20241016_lab.xml EX-101.LAB 36680
8 XBRL PRESENTATION FILE atnf-20241016_pre.xml EX-101.PRE 25253
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0217785-8k_180life_htm.xml XML 6301
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 241374223
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)